Oscar Health, Inc. (OSCR) is a publicly traded Healthcare sector company. As of May 21, 2026, OSCR trades at $23.18 with a market cap of $7.63B and a P/E ratio of -48.75. OSCR moved -4.57% today. Year to date, OSCR is +41.34%; over the trailing twelve months it is +42.20%. Its 52-week range spans $10.69 to $25.58. Analyst consensus is neutral with an average price target of $17.43. Rallies surfaces OSCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UBS Lifts Oscar Health Target to $20 After $679M Q1 Profit: UBS raised its price target on Oscar Health to $20 after Q1 revenue hit $4.65 billion and record profit of $679 million. EPS of $2.07 and over 50% membership growth drove a medical loss ratio of 70.5%, far exceeding analyst expectations.
| Metric | Value |
|---|---|
| Price | $23.18 |
| Market Cap | $7.63B |
| P/E Ratio | -48.75 |
| EPS | $-0.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.58 |
| 52-Week Low | $10.69 |
| Volume | 5.81M |
| Avg Volume | 0 |
| Revenue (TTM) | $13.30B |
| Net Income | $-39.39M |
| Gross Margin | 0.00% |
8 analysts cover OSCR: 0 strong buy, 0 buy, 6 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $17.43.